Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Evotec ventures into bispecific small molecules

Country: Germany

Bispecific, which is the term given to a molecule that binds to two different antigen, has largely been associated with therapeutic antibodies. But research has also been underway to discover whether the same concept can be applied to small molecules.

Read more

Galapagos and AbbVie to test combo CF therapy

Country: Netherlands

Galapagos NV and AbbVie Inc have raised the stakes in their bid to overtake Vertex Pharmaceuticals Inc in cystic fibrosis with plans to start human trials in 2017 of a new triple combination therapy for the disease.

Read more

Ipsen reports rise in specialty care sales

Country: France

Read more

Novo Nordisk posts an 8% rise in sales

Country: Denmark

Read more

Sanofi in rare disease research agreement

Country: France

Read more

Shire achieves double-digit revenue growth

Country: Ireland

Read more

Vernalis raises £40 million with equity placement

Country: United Kingdom

Read more

AZ to work with Craig Venter on genome analysis

Country: United Kingdom

Read more

Sanofi comments on Medivation’s rejection

Country: France

Read more

GSK increases exposure to bi-specifics

Country: United Kingdom

Read more

Bimagrumab misses primary endpoint

Country: Germany

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Oncology: Are too many combination therapies in progress?

OncologyComboTherapyApril2016.pdf

Highlights of the April 2016 MedNous issue

The April 2016 MedNous features:

Latest Mednous cover
  • Oncology Development
    Are too many combination therapies in progress?
  • Oncology Review
    Drug approvals accelerate
    By Bruno Pagliara
  • Commentary
    Liquid biopsies transform lung cancer therapy
    By Lukas Heukamp
  • Stock market performance
    European biotechs decline in the first quarter
  • Commentary
    How citrullination may link cancer and autoimmunity
    By Richard Goodfellow

The latest MedNous journal. Subscribe to download.